Home > Multinationals > Pfizer

Claimed by owner • Last Update Apr 25, 2026 • Suggest Edits • Claim Profile

Claimed by owner

Pfizer

Pharmaceuticals • United States

PUBLIC on NYSE on Jan, 2004

Pfizer

Sector Update: Healthcare Stocks Decline Thursday Afternoon

FreeCast surges premarket; Accenture, Novocure slide

AbbVie Gets EU Nod for Aquipta as Acute Treatment for Migraine

Polymyositis Market Research Report 2026-2036: Competitive Landscape is Dominated by Major Players Such As Teva Pharmaceuticals, Gilead Sciences, Roche, AbbVie, and Pfizer

Protalix BioTherapeutics, Inc. Q1 2026 Earnings Call Summary

Pfizer Inc. (PFE): One of the Best Safe Stocks to Invest in for Beginners

Richest countries in 2026: New measure of wealth pushes France and Germany out of top ten

Novo’s Once-Daily Sickle Cell Pill Hits Milestone. A Smaller Rival Is Sinking 24%.

Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing

Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says

Sector Update: Health Care Stocks Higher Late Afternoon

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Forget Teva: This Dividend Top Dog Is the Real Value Buy Today

$198.39 Bn Active Pharmaceutical Ingredients (API) Markets, 2030 by Synthesis (synthetic, Biotech), Potency (HPAPI), Product (mAbs, Hormones), Drug (OTC, Rx), Application (Diabetes, Oncology)

Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones

#Management Changes #Product Stage

These Stocks Are Moving the Most Today: Ford, Tesla, Pfizer, Broadcom, GitLab, Roku, Navan, and More

Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue

1 Profitable Stock on Our Buy List and 2 We Turn Down

#Customers

White House Touts $270 Billion Worth of Deals at Saudi-palooza

#Partners #Investment

Inside Yahoo Finance Invest 2025: Elon Musk's $1 trillion pay package, crypto cracks, and AI bubbles

Amazon upgraded, Adobe downgraded: Wall Street’s top analyst calls

Amazon upgraded, Adobe downgraded: Wall Street's top analyst calls

Padcev-Keytruda combo approved for NHS use in mUC

#Product Stage #Partners

Latest Fed cut signals, pharma relief rally, Apple TV+ price hike

Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB

Stocks to watch next week: BP, Diageo, Disney, Uber and WPP

Trump Aims Tariff Double Whammy at Industries, Nations by Aug. 1

AMD extends gains, solar stocks plummet, pharma stocks

Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say

#Customers, Investment, Management Changes, Layoffs

Column: How CEOs are threading the needle in talking about Israel and Gaza

#Customers, Partners

Moderna Shaves Off $7 Billion in Value After Pfizer Warning

#Customers #Investment

Pfizer jumps as investors look past Covid vaccine forecast to possible price hikes

Pfizer’s $43 Billion Seagen Takeover Faces EU Investigation

#Acquisition

A "boost for Jerusalem": German biotech company to open vaccine manufacturing plant in capital | CTech

#Partners #Investment

CytoReason, Pfizer ink $110M, 5-year extension of AI-powered drug development deal

Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason

#Partners

BioRap Technologies to collaborate with Pfizer on developing new immunomodulators

#Partners

Pfizer is a research-based pharmaceutical company. Pfizer discovers, develops, manufactures and markets leading prescription medicines and many of the world's best-known consumer brands. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.

Pfizer Pharmaceuticals Israel Ltd operates as a subsidiary of Pfizer. The company has sales office in Israel, and it also collaborates and partners with startups like CytoReason in 2019, and research institutes like the Technion Rappaport Institute in 2016.

Founded

1849

In Israel Since

1995

Employees Worldwide

50,000+

Employees In Israel

51-200

Market Cap

$142.94B

Market Cap Update

6/2026

Country

United States

News

(37)